Paving the Way for eHealth Interoperability: The EURO-CAS Project Launches Today

The EURO-CAS project launched operations today to deliver the eHealth Conformity Assessment Scheme for Europe in 2018. This scheme will help European health systems assess the conformity of eHealth products and solutions with international standards, and will enhance vendors' visibility by offering public recognition of conformity of their products. This will advance eHealth interoperability, help advance the European Digital Single Market in the health and care domain, and facilitate the sharing of information for better and more person-centred healthcare.

Led by IHE-Europe, a recognised leader in eHealth standards, the EURO-CAS consortium consists of representatives and competence centres of key European regions and Member States, as well as experts and international associations. Together they will assess the interoperability requirements of European health systems and analyse the existing testing and certification schemes, before developing and testing a European conformity scheme in several regions, guided by an advisory board of additional experts and policymakers. The finalised EURO-CAS model will be presented in November 2018 to the public.

"Lack of interoperability is both a reason for, and a result of, the fragmentation of eHealth markets in Europe and the endurance of information silos," says Karima Bourquard, Director of interoperability at IHE Europe, and scientific coordinator of EURO-CAS. "The EURO-CAS conformity assessment scheme will provide a comprehensive framework, with flexibility to allow better sustainability and harmonisation at European, national and regional levels."

EURO-CAS will build on the findings and results of a series of EU-funded projects that have advanced eHealth interoperability within and between Member States in the last years, and will provide a scheme consistent with the Refined eHealth European Interoperability Framework endorsed by representatives of all 28 European Member States in 2015.

The EURO-CAS conformity assessment scheme for Europe will consist of models, processes and tools that will enable and strengthen the capability of test centres to assess eHealth product and solutions, not only in regard to international standards and interoperability requirements of European eHealth projects, but also in regard to national and regional eHealth requirements.

The EURO-CAS project is committed to transparency and openness, and invites interested parties to join and contribute. They can engage face to face with consortium members during EURO-CAS events, or offer comments and feedback to key deliverables that will be offered for public consultation.

For further information, please visit:
http://www.euro-cas.eu

About the EURO-CAS project

The European eHealth Interoperability Conformity Assessment Scheme for Europe (EURO-CAS) will between 2016 and 2018 develop the sustainable Conformity Assessment Scheme (CAS) for Europe, which will promote the adoption and take-up of interoperability testing of eHealth solutions against identified eHealth standards and profiles defined in the eHealth European Interoperability Framework (eEIF). The project is led by IHE Europe (BE) and coordinated by EIBIR (AT), and joined by fourteen national and regional government bodies, competence centres, and associations. The EURO-CAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 727028.

Most Popular Now

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Record Year with More than 800 Exhibit…

9 - 11 April 2024, Berlin, Germany. DMEA 2024 kicks off today, focusing on the key issues in the digital transformation of the healthcare system. From now until 11 April over...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...